Related Experiment Video
Updated: Jul 4, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
A Prospective Case-Control Study of Helicobacter pylori and Systemic Inflammation in Colorectal Cancer Pathogenesis
Imad Sibhai1, Mounika Kotte2, Abubakar Gapizov3
1Medical Education, Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Ahmedabad, IND.
High neutrophil-to-lymphocyte ratio (NLR) strongly predicts colorectal cancer (CRC) risk in Pakistan. Active Helicobacter pylori infection showed no direct link, but interacted with NLR, suggesting inflammation modifies H. pylori effects. Further research is needed.
Area of Science:
- Gastroenterology and Oncology
- Inflammation and Carcinogenesis
Background:
- The association between Helicobacter pylori (H. pylori) infection and colorectal cancer (CRC) remains debated.
- Systemic inflammation is recognized as a driver of carcinogenesis.
- This study investigates H. pylori and neutrophil-to-lymphocyte ratio (NLR) in CRC risk.
Purpose of the Study:
- To assess the independent and interactive associations of active H. pylori infection and NLR with CRC risk.
- To evaluate H. pylori's role in CRC within a Pakistani cohort.
- To explore NLR as a potential biomarker for CRC risk stratification.
Main Methods:
- Prospective case-control study involving 105 CRC patients and 210 controls.
- Active H. pylori infection diagnosed via stool antigen testing.
- NLR dichotomized at the median (2.5) and analyzed using multivariate logistic regression.
Main Results:
- No significant difference in H. pylori prevalence between CRC cases and controls.
- High NLR (>2.5) was significantly associated with increased CRC risk (aOR = 300.86).
- A significant negative interaction was found between H. pylori and high NLR (aOR = 0.245).
Conclusions:
- Elevated NLR is a strong predictor of CRC in this Pakistani cohort.
- Active H. pylori infection did not show a direct association with CRC.
- Host inflammatory status, indicated by NLR, may modify H. pylori's impact on CRC; larger studies are required for confirmation.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
